Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026)

Lantheus Holdings (LNTH) posted quarterly Long-Term Investments of $58.3 million for Q1 2026, up 91.97% year-over-year from $30.4 million in Q1 2025, and up 5201.09% quarter-over-quarter from $1.1 million in Q4 2025.

Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Long-Term Investments for 3 consecutive years, with $58.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Long-Term Investments rose 91.97% year-over-year to $58.3 million; the TTM figure through Mar 2026 stood at $58.3 million (up 91.97% YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
  • Long-Term Investments grew to $58.3 million in Q1 2026 per LNTH's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $158.8 million in Q3 2024 and bottomed at $1.1 million in Q4 2025.
  • Historically, Long-Term Investments has averaged $74.4 million across 3 years, with a median of $52.4 million in 2025.
  • Annual changes were most pronounced in 2025 — Long-Term Investments slumped 78.14% — and 2026, when it surged 91.97%.
  • Lantheus Holdings' Long-Term Investments stood at $158.8 million in 2024, then plunged by 99.31% to $1.1 million in 2025, then surged by 5201.09% to $58.3 million in 2026.
  • Business Quant data shows LNTH's Long-Term Investments at $58.3 million in Q1 2026, $1.1 million in Q4 2025, and $46.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 92.58 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 63.23 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 1.14 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 149.10 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 60.00 Mn
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn 118.98 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 118.98 Mn
Mar 31, 2026 58.31 Mn
Dec 31, 2025 1.10 Mn
Sep 30, 2025 46.47 Mn
Jun 30, 2025 45.07 Mn
Mar 31, 2025 30.38 Mn
Sep 30, 2024 158.79 Mn
Jun 30, 2024 116.42 Mn
Mar 31, 2024 138.96 Mn